Turn Therapeutics (Direct Listing)(TTRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TTRX Turn Therapeutics (Direct Listing)

交易中 02-18 13:19:08 EST

3.26

-0.07

-2.10%

最高3.42	最低3.24	成交量4,419
今开3.42	昨收3.33	日振幅5.26%
总市值9,599万	流通市值5,825万	总股本2,945万
成交额1.45万	换手率0.02%	流通股本1,787万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TTRX","market":"US","secType":"STK","nameCN":"Turn Therapeutics (Direct Listing)","latestPrice":3.26,"timestamp":1771437910776,"preClose":3.33,"halted":0,"volume":4419,"delay":0,"changeRate":-0.021021021021021106,"floatShares":17868800,"shares":29445200,"eps":-0.12892704,"marketStatus":"交易中","change":-0.07,"latestTime":"02-18 13:19:08 EST","open":3.415,"high":3.415,"low":3.24,"amount":14517.1622529,"amplitude":0.052553,"askPrice":3.25,"askSize":100,"bidPrice":3.2,"bidSize":350,"shortable":0,"etf":0,"ttmEps":-0.12892704,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771448400000},"marketStatusCode":2,"adr":0,"listingDate":1759896000000,"exchange":"NASDAQ","adjPreClose":3.33,"preHourTrading":{"tag":"盘前","latestPrice":3.21,"preClose":3.33,"latestTime":"08:01 EST","volume":291,"amount":964.1099757,"timestamp":1771419693147,"change":-0.12,"changeRate":-0.036036,"amplitude":0.042042},"postHourTrading":{"tag":"盘后","latestPrice":3.2,"preClose":3.2,"latestTime":"16:10 EST","volume":3,"amount":9.99,"timestamp":1771362604801,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.48264},"requestUrl":"/m/hq/s/TTRX","defaultTab":"news","newsList":[{"id":"1112036493","title":"Turn Therapeutics 任命资本市场资深专家 Andrew Scott 为企业传播副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1112036493","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112036493?lang=zh_cn&edition=full","pubTime":"2025-11-05 06:09","pubTimestamp":1762294167,"startTime":"0","endTime":"0","summary":"Turn Therapeutics 任命资本市场资深专家 Andrew Scott 为企业传播副总裁","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1103328553","title":"Turn Therapeutics与领先的医用外科产品制造和分销商Medline签署全球供应、开发和许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1103328553","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103328553?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:31","pubTimestamp":1761823868,"startTime":"0","endTime":"0","summary":"Turn Therapeutics与领先的医用外科产品制造和分销商Medline签署全球供应、开发和许可协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1148388176","title":"Turn Therapeutics发布股东更新，强调在临床和战略里程碑上的持续进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1148388176","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148388176?lang=zh_cn&edition=full","pubTime":"2025-10-22 20:03","pubTimestamp":1761134630,"startTime":"0","endTime":"0","summary":"Turn Therapeutics发布股东更新，强调在临床和战略里程碑上的持续进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"1135785184","title":"异动解读 | Turn Therapeutics股东拟抛售股票，盘后大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135785184","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135785184?lang=zh_cn&edition=full","pubTime":"2025-10-10 04:34","pubTimestamp":1760042075,"startTime":"0","endTime":"0","summary":"周四盘后交易时段，Turn Therapeutics（股票代码：TTRX）股价大幅下跌5.43%，引发投资者关注。\n\n消息面上，Turn Therapeutics于当日提交了一份招股说明书，披露公司股东计划分批出售最多700万股股票。这一举动可能会增加市场上流通的股票数量，从而对股价造成压力。\n\n分析人士指出，股东大规模减持往往被市场视为对公司未来发展缺乏信心的信号。此外，增加的股票供给可能会导致股价下跌。投资者对这一消息反应强烈，导致Turn Therapeutics股价在盘后交易中出现显著跌幅。然而，具体影响还需进一步观察，因为实际售股数量和时间表尚未确定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TTRX"],"gpt_icon":0},{"id":"1171585948","title":"Turn Therapeutics提交招股书，涉及股东分批出售最多700万股股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1171585948","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171585948?lang=zh_cn&edition=full","pubTime":"2025-10-10 04:18","pubTimestamp":1760041095,"startTime":"0","endTime":"0","summary":"Turn Therapeutics提交招股书，涉及股东分批出售最多700万股股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTRX"],"gpt_icon":0},{"id":"2574255164","title":"美股异动 | 次新股Turn Therapeutics(TTRX.US)涨超144% 致力于开发下一代皮肤病、伤口和抗感染疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2574255164","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574255164?lang=zh_cn&edition=full","pubTime":"2025-10-09 23:51","pubTimestamp":1760025108,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，次新股Turn Therapeutics(TTRX.US)股价上涨，截至发稿，该股涨超144%，报16.95美元。Turn Therapeutics致力于开发下一代皮肤病、伤口和抗感染疗法。该公司拥有一种专有的递送平台技术 “PermaFusion®”，该技术旨在让水溶性的活性成分在无需乳化剂的情况下，以油性载体渗透进入皮肤、指甲或黏膜，从而增强可用性和减少刺激性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LENZ","BK4007","TTRX","BK4539","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://turntherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1398},{"period":"1month","weight":-0.2982},{"period":"3month","weight":0.1307},{"period":"6month","weight":-0.68},{"period":"ytd","weight":-0.1878}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0127},{"period":"3month","weight":0.0305},{"period":"6month","weight":0.0744},{"period":"1year","weight":0.12},{"period":"ytd","weight":0.0014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Turn Therapeutics Inc.最初成立于2015年1月6日，是一家特拉华州有限责任公司。该公司是一家制药和医疗器械开发公司，其核心技术基于专有平台，旨在提升药物性能。其专利混合工艺——商业名称为 PermaFusion——能够在不使用乳化剂的情况下，将极性水溶性活性药物成分（“APIs”）稳定地悬浮在油性载体中。其主要开发项目专注于皮肤病，包括中度至重度湿疹和甲癣。","exchange":"NASDAQ","name":"Turn Therapeutics (Direct Listing)","nameEN":"Turn Therapeutics (Direct Listing)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Turn Therapeutics (Direct Listing)(TTRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Turn Therapeutics (Direct Listing)(TTRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Turn Therapeutics (Direct Listing),TTRX,Turn Therapeutics (Direct Listing)股票,Turn Therapeutics (Direct Listing)股票老虎,Turn Therapeutics (Direct Listing)股票老虎国际,Turn Therapeutics (Direct Listing)行情,Turn Therapeutics (Direct Listing)股票行情,Turn Therapeutics (Direct Listing)股价,Turn Therapeutics (Direct Listing)股市,Turn Therapeutics (Direct Listing)股票价格,Turn Therapeutics (Direct Listing)股票交易,Turn Therapeutics (Direct Listing)股票购买,Turn Therapeutics (Direct Listing)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Turn Therapeutics (Direct Listing)(TTRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Turn Therapeutics (Direct Listing)(TTRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}